自体免疫疾病诊断市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、测试类型、疾病类型、最终用户、地区和竞争细分

2022年全球自体免疫疾病诊断市场估值为50.2亿美元，预计在整个预测期内将呈现强劲增长，预计复合年增长率（CAGR）为6.37%，预计到2028年将达到72.8亿美元。 ( AD) 是一种非传染性疾病，其特征是健康的免疫平衡被破坏，导致受影响的组织细胞出现异常反应。发炎、自体抗体和活化的 T 细胞在自体免疫疾病的发展中至关重要。虽然免疫细胞通常会辨识并对抗细菌和病毒等外部因素，但自体免疫疾病会导致免疫系统错误地攻击身体本身。一些自体免疫疾病专门针对特定器官。全球存在近80种自体免疫疾病，包括系统性红斑狼疮和类风湿性关节炎。美国自体免疫相关疾病协会（AARDA）显示，多达5,000万美国人患有自体免疫疾病，其中女性占75%。自体免疫疾病的诊断检查包括自体抗体测试、抗核抗体测试、全血球计数、C反应蛋白和红血球沉降速率。

主要市场驱动因素

对自体免疫疾病的认识不断增强

市场概况
预测期	2024-2028
2022 年市场规模	50.2亿美元
2028 年市场规模	72.8亿美元
2023-2028 年复合年增长率	6.37%
成长最快的细分市场	类风湿性关节炎
最大的市场	北美洲

压力、基因突变、不健康的饮食习惯和环境因素对自体免疫疾病的发展有显着影响。自体免疫疾病的全球流行导致对自体免疫疾病诊断的需求增加。例如，2020 年CDC 国家糖尿病统计报告指出，大约有140 万美国人患有1 型糖尿病，预计到2040 年这一数字将增加到210 万。公共和私人组织提高认识的努力有助于增加对自身免疫性疾病的了解。自体免疫协会（美国）等组织进行宣传活动，传播有关这些疾病的讯息。早期自体免疫疾病诊断对于最大限度地减少残疾、发病率和死亡率至关重要，从而推动自体免疫疾病诊断市场的成长。

自体免疫疾病的发生率增加

发炎性肠道疾病（IBD）和类风湿性关节炎等自体免疫疾病的盛行率不断上升，预计将对自体免疫疾病诊断市场产生重大影响。随着越来越多的人受到影响，人们更加重视早期发现和诊断。这种及时的诊断对于启动适当的治疗和管理策略至关重要。不同自体免疫疾病的发生率较高，需要进行多种诊断测试来准确区分这些疾病。这些发展促进了对综合诊断工具包的需求，以解决不同的疾病表现。

诊断技术的改进

技术进步使得多种自身抗体的同时辨识和测量成为可能。抗原微阵列和质谱等技术提高了检测与自体免疫疾病相关的特异性抗体或生物标记的敏感度。这些进步可以实现更精确和早期的检测。实验室自动化和传统技术的替代有助于扩大全球自体免疫疾病诊断市场。

主要市场挑战

需要多次诊断测试和延长週转时间

检测自体免疫疾病非常耗时，涉及各种测试场景，例如类风湿性关节炎、艾迪生氏病和桥本氏病的血清检测。由于没有单一的测试能够可靠地、高精度地检测特定的自体免疫疾病，因此需要进行多项实验室测试。这些测试可能包括完整的代谢检查、血球计数报告、血清学、流式细胞仪和 HLA 分型。这些测试的周转时间可能会延长，妨碍及时诊断。此外，高昂的测试成本和报销问题也是挑战。缺乏熟练的专业人员也会影响市场。

发展中地区的渗透率有限

儘管自体免疫疾病的盛行率不断上升，但有限的产品渗透率限制了市场扩张。发展中市场缺乏针对发炎性肠道疾病等新兴疾病的监测和资料库。流行病学资料和有效诊断的途径有限。缺乏意识阻碍了任命，阻碍了新兴国家的市场成长。

主要市场趋势

创新的自体免疫疾病检测方法

对准确诊断的需求催生了竞争格局，并鼓励了新参与者。鼓励老牌领导者之间的竞争性定价，亚太地区由于尚未开发的增长和不断扩大的患者人数而提供了潜力。研究提供了收入机会，而意识努力为独特诊断技术的发展创造了空间。自动化和传统技术替代有助于市场扩张。

现场护理和家庭检测

对方便、快速诊断的需求可能会推动现场护理和家庭检测套件的开发。患者可以方便地监测自己的病情，帮助更快做出治疗决定。家庭测试减轻了医疗机构的负担，使患者在医疗保健中发挥更积极的作用。

细分市场洞察

疾病类型

由于手术量大和患者意识相对较高，局部疾病诊断在市场上占据主导地位。在政府积极措施和意识提高的推动下，系统性疾病诊断预计将快速成长。

产品

由于已开发国家的高诊断率和经常性购买的推动，预计到 2023 年，试剂、检测方法和试剂盒领域将占据最大的市场份额。

区域洞察

亚太

由于自体免疫疾病盛行率增加、不健康的生活方式、政府措施和研究投资，亚太地区有望实现高速成长。印度的牛皮癣病例预计将增加，导致该地区患病率不断上升。

结论

由于意识的提高、自体免疫疾病发病率的增加、诊断的改进和创新方法，全球自体免疫疾病诊断市场正在经历成长。挑战包括需要进行多次测试、延长週转时间、在发展中地区的渗透率有限以及缺乏熟练的专业人员。趋势包括创新的检测方法和现场护理/家庭检测。疾病类型、产品和区域因​​素正在影响市场动态。由于自体免疫疾病盛行率不断扩大，亚太地区具有潜力。总体而言，自体免疫疾病诊断市场将会成长，重点是早期诊断和改进的测试技术。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产物（试剂、试剂盒、测定、仪器）
  • 依测试类型（抗核抗体测试、自体抗体测试、C 反应蛋白、全血球计数、尿液分析）
  • 依疾病类型（全身性、局部性）
  • 透过最终使用者（医院、诊断实验室、研究机构），
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按测试类型
  • 依疾病类型
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按测试类型
  • 依疾病类型
  • 按最终用户
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按测试类型
  • 依疾病类型
  • 按最终用户
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按测试类型
  • 依疾病类型
  • 按最终用户
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲自体免疫疾病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按测试类型
  • 依疾病类型
  • 按最终用户
• MEA：国家分析
  • 南非自体免疫疾病诊断
  • 沙乌地阿拉伯自体免疫疾病诊断
  • 阿联酋自体免疫疾病诊断

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球自体免疫疾病诊断市场：SWOT 分析

第14章：竞争格局

• 商业概览
• 服务产品
• 最近的发展
• 主要人员
• SWOT分析
  • Siemens Healthcare Private Limited
  • bioMerieux SA
  • Bio-rad Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-la Roche
  • Inova Diagnostics, Inc.
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific
  • Trinity Biotech Plc.
  • Hemagen Diagnostics, Inc.

第 15 章：策略建议

第 16 章：关于我们与免责声明

The Global Autoimmune Disease Diagnostics Market was valued at USD 5.02 Billion in 2022 and is expected to exhibit strong growth throughout the forecast period, projecting a Compound Annual Growth Rate (CAGR) of 6.37% and expected to reach USD 7.28 Billion through 2028. Autoimmune disease (AD) is a non-communicable ailment characterized by the disruption of healthy immunological equilibrium, leading to aberrant reactions in affected tissue cells. Inflammation, autoantibodies, and activated T cells are pivotal in the development of autoimmune disorders. While immune cells typically recognize and combat external agents like bacteria and viruses, autoimmune diseases lead to the immune system erroneously attacking the body itself. Some autoimmune conditions specifically target particular organs. Globally, almost 80 types of autoimmune diseases exist, including systemic lupus erythematosus and rheumatoid arthritis. The American Autoimmune Related Diseases Association (AARDA) reveals that up to 50 million Americans suffer from autoimmune diseases, with females constituting 75% of the cases. Diagnostic tests for autoimmune diseases encompass autoantibody tests, antinuclear antibody tests, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

Key Market Drivers

Growing Awareness of Autoimmune Diseases

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 5.02 Billion
Market Size 2028	USD 7.28 Billion
CAGR 2023-2028	6.37%
Fastest Growing Segment	Rheumatoid Athritis
Largest Market	North America

Stress, genetic mutations, unhealthy eating habits, and environmental factors contribute significantly to autoimmune disease development. The global prevalence of autoimmune diseases has led to an increased demand for autoimmune disease diagnostics. For instance, the 2020 CDC National Diabetes Statistics Report states that approximately 1.4 million Americans have Type-1 diabetes, with projections indicating a rise to 2.1 million by 2040. Heightened awareness efforts by public and private organizations have contributed to increased knowledge of autoimmune diseases. Organizations like the Autoimmune Association (U.S.) conduct awareness campaigns to disseminate information about these disorders. Early autoimmune disease diagnosis is pivotal in minimizing disability, morbidity, and mortality rates, driving the autoimmune disease diagnostics market's growth.

Increasing Incidence of Autoimmune Diseases

The increasing prevalence of autoimmune diseases, such as Inflammatory Bowel Disease (IBD) and rheumatoid arthritis, is expected to significantly impact the autoimmune disease diagnostics market. As more individuals are affected, there is a greater emphasis on early detection and diagnosis. This timely diagnosis is crucial for initiating appropriate treatment and management strategies. The higher incidence of different autoimmune diseases necessitates a diverse array of diagnostic tests that can accurately differentiate between these conditions. These developments contribute to the demand for a comprehensive diagnostic toolkit to address diverse disease presentations.

Improvement in Diagnostic Techniques

Technological advancements have enabled the simultaneous identification and measurement of multiple autoantibodies. Techniques like antigen microarrays and mass spectrometry offer increased sensitivity in detecting specific antibodies or biomarkers associated with autoimmune diseases. These advancements allow for more precise and early detection. Automation of laboratories and the replacement of conventional technologies contribute to the expansion of the global autoimmune disease diagnostics market.

Key Market Challenges

Need for Multiple Diagnostic Tests and Prolonged Turnaround Time

Detecting autoimmune diseases is time-consuming, involving various testing scenarios like serum testing for rheumatoid arthritis, Addison's disease, and Hashimoto's disease. Multiple laboratory tests are necessary due to no single test reliably detecting a specific autoimmune disease with high accuracy. These tests may include a complete metabolic panel, blood count report, serologies, flow cytometry, and HLA typing. Turnaround times for these tests can be extended, impeding prompt diagnosis. Moreover, high test costs and reimbursement issues are challenges. The lack of skilled professionals also impacts the market.

Limited Penetration in Developing Regions

While autoimmune diseases' prevalence is rising, limited product penetration restricts market expansion. Developing markets lack surveillance and databases for emerging diseases like IBD. Epidemiological data and access to efficient diagnostics are limited. Lack of awareness hampers appointments, impeding market growth in emerging countries.

Key Market Trends

Innovative Autoimmune Disease Detection Approaches

The demand for accurate diagnosis fosters a competitive landscape, encouraging new players. Competitive pricing among established leaders is encouraged, and the Asia-Pacific region offers potential due to untapped growth and an expanding patient population. Research studies present revenue opportunities, and awareness efforts create room for unique diagnostic techniques' development. Automation and conventional technology replacement contribute to market expansion.

Point-of-Care and Home Testing

Demand for convenient and rapid diagnostics could drive point-of-care and home testing kits' development. Patients can monitor their conditions conveniently, aiding quicker treatment decisions. Home testing reduces healthcare facility burden and allows patients to play a more active role in their healthcare.

Segmental Insights

Disease Type

Localized disease diagnostics dominated the market due to large procedure volumes and relatively higher patient awareness. Systemic disease diagnostics are projected to grow rapidly, fueled by favorable government initiatives and increased awareness.

Product

The reagents, assays, and kits segment is expected to hold the largest market share by 2023, driven by high diagnosis rates and recurring purchases in developed countries.

Regional Insights

Asia-Pacific

The Asia-Pacific region is poised for high growth due to increasing autoimmune disease prevalence, unhealthy lifestyles, government initiatives, and research investments. Psoriasis cases in India are projected to rise, contributing to the region's growing prevalence.

Conclusion

The Global Autoimmune Disease Diagnostics Market is experiencing growth due to rising awareness, increasing autoimmune disease incidence, diagnostic improvements, and innovative approaches. Challenges include the need for multiple tests, extended turnaround time, limited penetration in developing regions, and a shortage of skilled professionals. Trends include innovative detection methods and point-of-care/home testing. Disease type, product, and regional factors are influencing market dynamics. The Asia-Pacific region holds potential due to expanding autoimmune disease prevalence. Overall, the autoimmune disease diagnostics market is set to grow with a focus on early diagnosis and improved testing techniques.

Key Market Players

• Siemens Healthcare Private Limited
• bioMerieux SA
• Bio-rad Laboratories
• Beckman Coulter, Inc.
• F. Hoffmann-la Roche
• Inova Diagnostics, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific
• Trinity Biotech Plc.
• Hemagen Diagnostics, Inc.

Report Scope:

In this report, the Global Autoimmune Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Autoimmune Disease Diagnostics Market, By Product:

• Reagents
• Kits
• Assays
• Instruments

Autoimmune Disease Diagnostics Market, By Test Type:

• Antinuclear Antibody Tests
• Autoantibody Tests
• C-reactive Protein
• Complete Blood Count
• Urinalysis

Autoimmune Disease Diagnostics Market, By Disease Type:

• Systemic
• Localized

Autoimmune Disease Diagnostics Market, By End User:

• Hospitals
• Diagnostic Labs
• Research Institutes

Autoimmune Disease Diagnostics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Autoimmune Disease Diagnostics Market.

Available Customizations:

• Global Autoimmune Disease Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Autoimmune Disease Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents, Kits, Assays, Instruments)
  • 5.2.2. By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein, Complete Blood Count, Urinalysis)
  • 5.2.3. By Disease Type (Systemic, Localized)
  • 5.2.4. By End User (Hospitals, Diagnostic Labs, Research Institutes),
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Market Map

6. North America Autoimmune Disease Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Test Type
  • 6.2.3. By Disease Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Autoimmune Disease Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Disease Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Autoimmune Disease Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Disease Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Autoimmune Disease Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Disease Type
      • 6.3.3.2.4. By End User

7. Europe Autoimmune Disease Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Test Type
  • 7.2.3. By Disease Type
  • 7.2.4. By End User
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Autoimmune Disease Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Disease Type
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Autoimmune Disease Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Disease Type
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Autoimmune Disease Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Disease Type
      • 7.3.3.2.4. By End User
  • 7.3.4. France Autoimmune Disease Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Disease Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Autoimmune Disease Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Disease Type
      • 7.3.5.2.4. By End User

8. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Test Type
  • 8.2.3. By Disease Type
  • 8.2.4. By End User
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Autoimmune Disease Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Disease Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Autoimmune Disease Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Disease Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Autoimmune Disease Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Disease Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Autoimmune Disease Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Disease Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Autoimmune Disease Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Disease Type
      • 8.3.5.2.4. By End User

9. South America Autoimmune Disease Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Test Type
  • 9.2.3. By Disease Type
  • 9.2.4. By End User
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Autoimmune Disease Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Disease Type
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Autoimmune Disease Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Disease Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Autoimmune Disease Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Disease Type
      • 9.3.3.2.4. By End User

10. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Test Type
  • 10.2.3. By Disease Type
  • 10.2.4. By End User
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Autoimmune Disease Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Disease Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Disease Type
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Autoimmune Disease Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Disease Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Autoimmune Disease Diagnostics Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Services Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Siemens Healthcare Private Limited
  • 14.5.2. bioMerieux SA
  • 14.5.3. Bio-rad Laboratories
  • 14.5.4. Beckman Coulter, Inc.
  • 14.5.5. F. Hoffmann-la Roche
  • 14.5.6. Inova Diagnostics, Inc.
  • 14.5.7. Myriad Genetics, Inc.
  • 14.5.8. Thermo Fisher Scientific
  • 14.5.9. Trinity Biotech Plc.
  • 14.5.10. Hemagen Diagnostics, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer